Dr. Markman on Unmet Needs in Endometrial and Cervical Cancers

Maurie Markman, MD
Published: Tuesday, Jan 08, 2019



Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care® for Gynecological Cancers, discusses unmet needs in endometrial and cervical cancers.

Cervical cancer should essentially be eradicated by the human papillomavirus (HPV) vaccine, according to Markman, but although the vaccine is a major advancement, its use is not as universal as it should be. When it comes to cervical cancer, prevention via HPV vaccination and screening are important—but beyond that, there are not many effective therapies available for those with advanced disease.

Although there was a recent FDA approval for the immunotherapy agent cemiplimab (Libtayo) in the advanced setting, but physicians still use platinum-based chemotherapy and radiation in the early-stage setting.

For endometrial cancer, early detection in terms of identifying symptoms is crucial, Markman says. Currently, there is an epidemic of endometrial cancer associated with the high incidence of obesity in the United States, says Markman. Because obesity is a major risk factor for this disease, prevention and treatment of endometrial cancer should focus on weight management.
SELECTED
LANGUAGE


Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care® for Gynecological Cancers, discusses unmet needs in endometrial and cervical cancers.

Cervical cancer should essentially be eradicated by the human papillomavirus (HPV) vaccine, according to Markman, but although the vaccine is a major advancement, its use is not as universal as it should be. When it comes to cervical cancer, prevention via HPV vaccination and screening are important—but beyond that, there are not many effective therapies available for those with advanced disease.

Although there was a recent FDA approval for the immunotherapy agent cemiplimab (Libtayo) in the advanced setting, but physicians still use platinum-based chemotherapy and radiation in the early-stage setting.

For endometrial cancer, early detection in terms of identifying symptoms is crucial, Markman says. Currently, there is an epidemic of endometrial cancer associated with the high incidence of obesity in the United States, says Markman. Because obesity is a major risk factor for this disease, prevention and treatment of endometrial cancer should focus on weight management.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Show Me the Data™: Leveraging Evidence to Optimize Applications of PARP Inhibitor Strategies in Ovarian CancerJun 29, 20191.5
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x